OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
Kim Papp, Jacek C. Szepietowski, Leon Kircik, et al.
Journal of the American Academy of Dermatology (2022) Vol. 88, Iss. 5, pp. 1008-1016
Closed Access | Times Cited: 52
Kim Papp, Jacek C. Szepietowski, Leon Kircik, et al.
Journal of the American Academy of Dermatology (2022) Vol. 88, Iss. 5, pp. 1008-1016
Closed Access | Times Cited: 52
Showing 26-50 of 52 citing articles:
Topical Therapy for Atopic Dermatitis
Maria Gnarra Buethe, Caitlyn Kellogg, Young‐Joon Seo, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 4, pp. 569-575
Closed Access | Times Cited: 2
Maria Gnarra Buethe, Caitlyn Kellogg, Young‐Joon Seo, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 4, pp. 569-575
Closed Access | Times Cited: 2
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
Eric L. Simpson, Leon Kircik, Andrew Blauvelt, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2139-2151
Open Access | Times Cited: 2
Eric L. Simpson, Leon Kircik, Andrew Blauvelt, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2139-2151
Open Access | Times Cited: 2
Atopic dermatitis: pathogenesis and therapeutic intervention
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Topical Prescription Management
Katie Lovell, Bradley G. Ackerson, Ryan K. Thorpe, et al.
Advances in experimental medicine and biology (2024), pp. 117-129
Closed Access | Times Cited: 1
Katie Lovell, Bradley G. Ackerson, Ryan K. Thorpe, et al.
Advances in experimental medicine and biology (2024), pp. 117-129
Closed Access | Times Cited: 1
Special Considerations of Atopic Dermatitis in Skin of Color
Anthony Marcelletti, Divya M. Shan, Warda Abdi, et al.
Advances in experimental medicine and biology (2024), pp. 45-57
Closed Access | Times Cited: 1
Anthony Marcelletti, Divya M. Shan, Warda Abdi, et al.
Advances in experimental medicine and biology (2024), pp. 45-57
Closed Access | Times Cited: 1
Ruxolitinib as a CaMKII Inhibitor for the Treatment of Cardiac Arrhythmias: Applications and Prospects
Qingbo Guo, Yuxin Huo, Qiming Liu, et al.
Heart Rhythm (2024)
Open Access | Times Cited: 1
Qingbo Guo, Yuxin Huo, Qiming Liu, et al.
Heart Rhythm (2024)
Open Access | Times Cited: 1
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells
Remo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Remo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies
Eric L. Simpson, Matthias Augustin, Diamant Thaçi, et al.
American Journal of Clinical Dermatology (2024)
Open Access | Times Cited: 1
Eric L. Simpson, Matthias Augustin, Diamant Thaçi, et al.
American Journal of Clinical Dermatology (2024)
Open Access | Times Cited: 1
Inhibidores de JAK en dermatitis atópica, nuevas perspectivas
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes
Kimberly A. Arnold, Liam F. Peterson, Lisa A. Beck, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9243-9243
Open Access | Times Cited: 3
Kimberly A. Arnold, Liam F. Peterson, Lisa A. Beck, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9243-9243
Open Access | Times Cited: 3
[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions
Lisa Pagan, Bertine W. Huisman, Michelle van der Wurff, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 2
Lisa Pagan, Bertine W. Huisman, Michelle van der Wurff, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 2
Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
Izabella Ryguła, Wojciech Pikiewicz, Konrad Kaminiów
Molecules (2023) Vol. 28, Iss. 24, pp. 8064-8064
Open Access | Times Cited: 2
Izabella Ryguła, Wojciech Pikiewicz, Konrad Kaminiów
Molecules (2023) Vol. 28, Iss. 24, pp. 8064-8064
Open Access | Times Cited: 2
Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy
Eric L. Simpson, Leon Kircik, Andrew Blauvelt, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 12, pp. 1523-1530
Open Access | Times Cited: 2
Eric L. Simpson, Leon Kircik, Andrew Blauvelt, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 12, pp. 1523-1530
Open Access | Times Cited: 2
Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczema
Yael Renert‐Yuval, Emma Guttman‐Yassky
The Lancet (2024) Vol. 404, Iss. 10451, pp. 409-411
Closed Access
Yael Renert‐Yuval, Emma Guttman‐Yassky
The Lancet (2024) Vol. 404, Iss. 10451, pp. 409-411
Closed Access
Moderne topische Arzneimittel – neue Entwicklungen in Galenik und Pharmakologie
Adina Eichner, Johannes Wohlrab
Deleted Journal (2024) Vol. 75, Iss. 10, pp. 753-761
Closed Access
Adina Eichner, Johannes Wohlrab
Deleted Journal (2024) Vol. 75, Iss. 10, pp. 753-761
Closed Access
Role of allergen immunotherapy and biologics in allergic diseases
Xiaoying Zhou, Elisabeth M. Simonin, Youn Soo Jung, et al.
Current Opinion in Immunology (2024) Vol. 91, pp. 102494-102494
Closed Access
Xiaoying Zhou, Elisabeth M. Simonin, Youn Soo Jung, et al.
Current Opinion in Immunology (2024) Vol. 91, pp. 102494-102494
Closed Access
Effect of systemic immunomodulatory therapies on mental health in atopic dermatitis: a systematic review and network meta-analysis
Ming Liu, Kaihua Zhang, Kelu Yang, et al.
(2024)
Closed Access
Ming Liu, Kaihua Zhang, Kelu Yang, et al.
(2024)
Closed Access
Systemic Therapies for Atopic Dermatitis
S. Saed, Kelly Hawkins, Nicole Ramsey, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 3172-3174.e11
Closed Access
S. Saed, Kelly Hawkins, Nicole Ramsey, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 3172-3174.e11
Closed Access
Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis
Sibel Ali, Ana Ion, Olguţa Anca Orzan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1425-1425
Open Access
Sibel Ali, Ana Ion, Olguţa Anca Orzan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1425-1425
Open Access
Generalized extragenital lichen sclerosus et atrophicus in skin of color
Christina Jiang, Elnara Muradova, Jun Lu
JAAD Case Reports (2023) Vol. 40, pp. 63-66
Open Access | Times Cited: 1
Christina Jiang, Elnara Muradova, Jun Lu
JAAD Case Reports (2023) Vol. 40, pp. 63-66
Open Access | Times Cited: 1
Update on the Treatment of Atopic Dermatitis
Elisabeth Riedl
hautnah (2024) Vol. 23, Iss. 2, pp. 93-99
Open Access
Elisabeth Riedl
hautnah (2024) Vol. 23, Iss. 2, pp. 93-99
Open Access
Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus
Mark Boguniewicz, Moise L. Levy, Lawrence F. Eichenfield, et al.
Deleted Journal (2024) Vol. 14, pp. 200121-200121
Open Access
Mark Boguniewicz, Moise L. Levy, Lawrence F. Eichenfield, et al.
Deleted Journal (2024) Vol. 14, pp. 200121-200121
Open Access
Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
Andrew Blauvelt, Howard Kallender, Daniel Sturm, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 11, pp. 3161-3174
Open Access
Andrew Blauvelt, Howard Kallender, Daniel Sturm, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 11, pp. 3161-3174
Open Access
